Assessing the economic value of anticancer therapies:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Berlin [u.a.]
Springer
1998
|
| Schriftenreihe: | Recent results in cancer research
148 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XI, 285 S. |
| ISBN: | 3540640304 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011984788 | ||
| 003 | DE-604 | ||
| 005 | 19980925 | ||
| 007 | t | ||
| 008 | 980526s1998 gw |||| 00||| eng d | ||
| 016 | 7 | |a 952463156 |2 DE-101 | |
| 020 | |a 3540640304 |9 3-540-64030-4 | ||
| 035 | |a (OCoLC)38180353 | ||
| 035 | |a (DE-599)BVBBV011984788 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-355 |a DE-19 |a DE-29 |a DE-12 |a DE-578 | ||
| 050 | 0 | |a RC261 | |
| 082 | 0 | |a 616.99/4 |2 21 | |
| 082 | 0 | |a 338.4/361699406 |2 21 | |
| 084 | |a XH 3103 |0 (DE-625)152887:12909 |2 rvk | ||
| 084 | |a XH 3900 |0 (DE-625)152896:13129 |2 rvk | ||
| 100 | 1 | |a Neymark, Niels |d 1954- |e Verfasser |0 (DE-588)118042939 |4 aut | |
| 245 | 1 | 0 | |a Assessing the economic value of anticancer therapies |c N. Neymark |
| 264 | 1 | |a Berlin [u.a.] |b Springer |c 1998 | |
| 300 | |a XI, 285 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Recent results in cancer research |v 148 | |
| 650 | 7 | |a Economische waarde |2 gtt | |
| 650 | 7 | |a Kanker |2 gtt | |
| 650 | 7 | |a Therapieën |2 gtt | |
| 650 | 4 | |a Cancer |x Treatment |x Cost effectiveness | |
| 650 | 4 | |a Cancer |x Treatment |x Economic aspects | |
| 650 | 4 | |a Cost-Benefit Analysis |x methods |v Review | |
| 650 | 4 | |a Health Care Costs |v Review | |
| 650 | 4 | |a Medical care, Cost of | |
| 650 | 4 | |a Neoplasms |x economics |v Review | |
| 650 | 4 | |a Neoplasms |x therapy |v Review | |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | 2 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 830 | 0 | |a Recent results in cancer research |v 148 |w (DE-604)BV000000043 |9 148 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008110032&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008110032 | ||
Datensatz im Suchindex
| _version_ | 1804126579353190400 |
|---|---|
| adam_text | Contents
Introduction l
Epidemiology of Cancer 9
Cancer and Some Basics of the Main Treatment Modalities 15
Cancer Understood as a Cellular Disease 15
The Main Treatment Modalities 18
Surgical Therapy 18
Radiotherapy 19
Chemotherapy 20
Hormonal Therapy 22
Biologic Therapy 23
Supportive Treatment 24
A Brief Introduction to Economic Evaluation 28
Cost of Illness Analysis 29
The Meaning of the Term Economic Evaluation 32
A Framework for Economic Evaluations 36
Formulation of the Objectives of Treatment 37
Choice of Treatment Alternatives 37
Identification and Quantification of Costs and Effects . 38
Valuation of the Costs 39
Presentation and Interpretation of the Results 39
The Economic Burden of Cancer 42
Methodological Considerations 42
Calculations 46
Concluding Remarks 52
Breast Cancer 54
Treatment Options 55
Economic Evaluations 60
i Concluding Remarks 74
I
X Contents
Lung Cancer 79
Introduction 79
Small Cell Lung Cancer 80
Non Small Cell Lung Cancer 82
Economic Evaluations 84
Concluding Remarks 93
Colorectal Cancer 97
Introduction 97
Colon Cancer 98
Rectal Cancer 100
Economic Evaluations 101
Concluding Remarks Ill
Prostate Cancer 114
Treatment Options 116
Economic Evaluations 121
Concluding Remarks 128
Genitourinary and Gynecological Cancer 133
Bladder Cancer 133
Economic Evaluations 134
Concluding Remarks 135
Testis Cancer 136
Seminomas 137
Nonseminomas 138
Economic Evaluations 140
Concluding Remarks 145
Ovarian Cancer 149
Economic Evaluations 150
Concluding Remarks 153
Hematological Malignancies 156
Leukemias 156
Acute Leukemias 157
Chronic Leukemias 160
Lymphomas 162
Non Hodgkin s Disease 163
Hodgkin s Disease 165
Economic Evaluations 167
Concluding Remarks 178
Supportive Care I: Emesis and Infections 183
Introduction 183 ;
Emesis and Antiemetic Therapy 184
Economic Evaluations 186 !
Concluding Remarks 192 I
Contents XI
Infections in the Cancer Patient and Treatment
with Antimicrobials 195
Evaluation and Management of Febrile Cancer Patients . 197
Economic Evaluations of Antibiotic Treatments 202
Concluding Remarks 208
Supportive Care II: Hematological Support 211
Introduction 211
Febrile Neutropenia and Colony Stimulating Factors 212
Economic Evaluations 215
Concluding Remarks 226
Transplantation of Blood Progenitor or Stem Cells 232
Bone Marrow Transplantation 232
Peripheral Blood Stem Cell Transplantation 237
Economic Evaluations 238
Concluding Remarks 243
Palliative Care 248
Economic Evaluations of Pain Management 254
Economic Evaluations of Alternatives in Palliative Care . . . 256
Concluding Remarks 259
Conclusion 263
General Methodological Issues in Economic Evaluations
of Health Care 269
Relevance of Outcome Measures 269
Costs or Charges? 270
Should Data Be Collected in Clinical Trials? 271
Final Remarks 274
References 277
|
| any_adam_object | 1 |
| author | Neymark, Niels 1954- |
| author_GND | (DE-588)118042939 |
| author_facet | Neymark, Niels 1954- |
| author_role | aut |
| author_sort | Neymark, Niels 1954- |
| author_variant | n n nn |
| building | Verbundindex |
| bvnumber | BV011984788 |
| callnumber-first | R - Medicine |
| callnumber-label | RC261 |
| callnumber-raw | RC261 |
| callnumber-search | RC261 |
| callnumber-sort | RC 3261 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XH 3103 XH 3900 |
| ctrlnum | (OCoLC)38180353 (DE-599)BVBBV011984788 |
| dewey-full | 616.99/4 338.4/361699406 |
| dewey-hundreds | 600 - Technology (Applied sciences) 300 - Social sciences |
| dewey-ones | 616 - Diseases 338 - Production |
| dewey-raw | 616.99/4 338.4/361699406 |
| dewey-search | 616.99/4 338.4/361699406 |
| dewey-sort | 3616.99 14 |
| dewey-tens | 610 - Medicine and health 330 - Economics |
| discipline | Wirtschaftswissenschaften Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02193nam a2200577 cb4500</leader><controlfield tag="001">BV011984788</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19980925 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980526s1998 gw |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">952463156</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540640304</subfield><subfield code="9">3-540-64030-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)38180353</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011984788</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC261</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4</subfield><subfield code="2">21</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/361699406</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3103</subfield><subfield code="0">(DE-625)152887:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3900</subfield><subfield code="0">(DE-625)152896:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Neymark, Niels</subfield><subfield code="d">1954-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)118042939</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Assessing the economic value of anticancer therapies</subfield><subfield code="c">N. Neymark</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 285 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Recent results in cancer research</subfield><subfield code="v">148</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Economische waarde</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Therapieën</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="x">Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cost-Benefit Analysis</subfield><subfield code="x">methods</subfield><subfield code="v">Review</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Care Costs</subfield><subfield code="v">Review</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care, Cost of</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">economics</subfield><subfield code="v">Review</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield><subfield code="v">Review</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Recent results in cancer research</subfield><subfield code="v">148</subfield><subfield code="w">(DE-604)BV000000043</subfield><subfield code="9">148</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008110032&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008110032</subfield></datafield></record></collection> |
| id | DE-604.BV011984788 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:19:42Z |
| institution | BVB |
| isbn | 3540640304 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008110032 |
| oclc_num | 38180353 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-29 DE-12 DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-29 DE-12 DE-578 |
| physical | XI, 285 S. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Springer |
| record_format | marc |
| series | Recent results in cancer research |
| series2 | Recent results in cancer research |
| spelling | Neymark, Niels 1954- Verfasser (DE-588)118042939 aut Assessing the economic value of anticancer therapies N. Neymark Berlin [u.a.] Springer 1998 XI, 285 S. txt rdacontent n rdamedia nc rdacarrier Recent results in cancer research 148 Economische waarde gtt Kanker gtt Therapieën gtt Cancer Treatment Cost effectiveness Cancer Treatment Economic aspects Cost-Benefit Analysis methods Review Health Care Costs Review Medical care, Cost of Neoplasms economics Review Neoplasms therapy Review Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Therapie (DE-588)4059798-2 s Kosten-Nutzen-Analyse (DE-588)4032589-1 s DE-604 Recent results in cancer research 148 (DE-604)BV000000043 148 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008110032&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Neymark, Niels 1954- Assessing the economic value of anticancer therapies Recent results in cancer research Economische waarde gtt Kanker gtt Therapieën gtt Cancer Treatment Cost effectiveness Cancer Treatment Economic aspects Cost-Benefit Analysis methods Review Health Care Costs Review Medical care, Cost of Neoplasms economics Review Neoplasms therapy Review Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Therapie (DE-588)4059798-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4032589-1 (DE-588)4059798-2 (DE-588)4073781-0 |
| title | Assessing the economic value of anticancer therapies |
| title_auth | Assessing the economic value of anticancer therapies |
| title_exact_search | Assessing the economic value of anticancer therapies |
| title_full | Assessing the economic value of anticancer therapies N. Neymark |
| title_fullStr | Assessing the economic value of anticancer therapies N. Neymark |
| title_full_unstemmed | Assessing the economic value of anticancer therapies N. Neymark |
| title_short | Assessing the economic value of anticancer therapies |
| title_sort | assessing the economic value of anticancer therapies |
| topic | Economische waarde gtt Kanker gtt Therapieën gtt Cancer Treatment Cost effectiveness Cancer Treatment Economic aspects Cost-Benefit Analysis methods Review Health Care Costs Review Medical care, Cost of Neoplasms economics Review Neoplasms therapy Review Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Therapie (DE-588)4059798-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Economische waarde Kanker Therapieën Cancer Treatment Cost effectiveness Cancer Treatment Economic aspects Cost-Benefit Analysis methods Review Health Care Costs Review Medical care, Cost of Neoplasms economics Review Neoplasms therapy Review Kosten-Nutzen-Analyse Therapie Krebs Medizin |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008110032&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000000043 |
| work_keys_str_mv | AT neymarkniels assessingtheeconomicvalueofanticancertherapies |